McDermott Will & Emery

OSG Completes Reorganization with Strong Balance Sheet and New Ownership Group

Retrieved on: 
월요일, 12월 4, 2023
OSG, Investment, McDermott Will & Emery, Management, Sitrick and Company, Plan, Effective date

"We would like to thank each of our advisors for their guidance and tireless efforts that supported our smooth reorganization.

Key Points: 
  • "We would like to thank each of our advisors for their guidance and tireless efforts that supported our smooth reorganization.
  • OSG continues to be a leading innovator in providing solutions for its customers' billing and payment needs.
  • As part of the transaction, OSG's balance sheet has been completely recapitalized with only modest leverage and meaningful balance sheet cash, positioning the Company to capitalize on market growth and investments to serve its customers.
  • The ad hoc group of first lien lenders was advised by Paul Hastings LLP as legal counsel and Perella Weinberg Partners LP as investment banker.

Gemspring Capital Announces Sale of Valant

Retrieved on: 
월요일, 12월 4, 2023
Sale, Investment, Ram, McDermott Will & Emery, Software, Software as a service, Management, Durrantia resurgens, Anja Valant

WESTPORT, Conn., Dec. 4, 2023 /PRNewswire/ -- Gemspring Capital, a middle-market private equity firm, announced today that it has completed the sale of portfolio company Valant Medical Solutions ('Valant" or the "Company"), a provider of SaaS-based electronic health record and practice management software for behavioral health providers, to an affiliate of Resurgens Technology Partners ("Resurgens").

Key Points: 
  • WESTPORT, Conn., Dec. 4, 2023 /PRNewswire/ -- Gemspring Capital, a middle-market private equity firm, announced today that it has completed the sale of portfolio company Valant Medical Solutions ('Valant" or the "Company"), a provider of SaaS-based electronic health record and practice management software for behavioral health providers, to an affiliate of Resurgens Technology Partners ("Resurgens").
  • Founded in 2005 and backed by Gemspring since 2019, Valant provides a comprehensive and differentiated software platform that enables customers to manage key operational, clinical, and financial workflows to drive optimal business and patient outcomes.
  • "It's been incredibly rewarding to support Ram and the entire Valant team during this chapter of exceptional growth," said Aron Grossman, Managing Director at Gemspring.
  • Aeris Partners served as financial advisor and McDermott Will & Emery LLP served as legal counsel to Valant and Gemspring.

Provident Healthcare Partners Advises East Coast Institute for Research in its Partnership with Gauge Capital

Retrieved on: 
화요일, 11월 28, 2023
Ophthalmology, Entrepreneurship, Provident, ECIR, Rest, Obesity, Dyslipidemia, McDermott Will & Emery, Partnership, Phase, Growth, Diabetes, Gauge

BOSTON and NEW YORK, Nov. 28, 2023 /PRNewswire/ -- Provident Healthcare Partners ("Provident"), a leading healthcare investment banking firm, announced it has advised East Coast Institute for Research ("ECIR") in its partnership with Gauge Capital to provide a growth investment for the Company.

Key Points: 
  • BOSTON and NEW YORK, Nov. 28, 2023 /PRNewswire/ -- Provident Healthcare Partners ("Provident"), a leading healthcare investment banking firm, announced it has advised East Coast Institute for Research ("ECIR") in its partnership with Gauge Capital to provide a growth investment for the Company.
  • ECIR is a preeminent Southeast clinical research site management organization with eight sites in Florida and Georgia, 14 partnered provider practices, and 26 principal investigators.
  • Axia Legal Services served as legal counsel to ECIR and McDermott Will & Emery served as legal counsel to Gauge Capital.
  • "The Gauge team separated themselves as an ideal partner for ECIR given their dedicated thesis in the research site space and strong track record of providing growth capital for founder-led healthcare organizations."

Bloomberg Tax Launches New Portfolio to Help Practitioners Navigate State Corporate Income Taxes

Retrieved on: 
월요일, 11월 27, 2023
Tax, McDermott Will & Emery, Ryan LLC, File, Portfolio

ARLINGTON, Va., Nov. 27, 2023 /PRNewswire/ -- Bloomberg Tax & Accounting today announced the release of a new Tax Management Portfolio, Corporate Income Tax: General Principles.

Key Points: 
  • ARLINGTON, Va., Nov. 27, 2023 /PRNewswire/ -- Bloomberg Tax & Accounting today announced the release of a new Tax Management Portfolio, Corporate Income Tax: General Principles.
  • Authored by Art Rosen of McDermott Will & Emery, Mark Nachbar and Duane Dobson of Ryan, LLC, and Jaye Calhoun of Kean Miller, the Portfolio addresses the complex world of state corporate income taxes and the broad principles underpinning state corporate income taxation.
  • The new Portfolio offers practical guidance from seasoned practitioners for early career tax professionals or other tax professionals who are less familiar with state corporate income taxation given the complexity of state corporate income taxes that multinational companies are increasingly required to pay.
  • "This Tax Management Portfolio, Corporate Income Tax: General Principles, will provide junior tax professionals with a full understanding of the principles and nuances of state corporate income taxation," said author Art Rosen, partner emeritus at McDermott Will & Emery.

Virgin Pulse and HealthComp Complete Merger

Retrieved on: 
목요일, 11월 9, 2023
Health, Behavior, Kirkland & Ellis, Ropes & Gray, Virgin Group, Homebase, Blackstone, McDermott Will & Emery, Pulse, Medical device, R.I

PROVIDENCE, R.I. and FRESNO, Calif., Nov. 9, 2023 /PRNewswire/ -- Virgin Pulse, a leading global digital-first health, wellbeing, and navigation company, and HealthComp, a next-generation benefits and analytics platform, today announced the completion of their merger. Together, the new company will address the issues of increasing healthcare costs and complexity with an innovative, holistic approach that brings together engaging technology, data, and expert services in an all-in-one platform.

Key Points: 
  • New company poised to improve costs and outcomes with comprehensive employer health platform that combines AI-powered technology, valuable data insights, and live expert support
    PROVIDENCE, R.I. and FRESNO, Calif., Nov. 9, 2023 /PRNewswire/ -- Virgin Pulse , a leading global digital-first health, wellbeing, and navigation company, and HealthComp , a next-generation benefits and analytics platform, today announced the completion of their merger.
  • Together the company will deliver:
    "Today is an exciting day for our clients, members, and employees," said Chris Michalak, CEO of Virgin Pulse and HealthComp.
  • J.P. Morgan Securities LLC acted as financial advisor to HealthComp.
  • Evercore acted as financial advisor to Virgin Pulse, with Kirkland & Ellis LLP and McDermott Will & Emery LLP serving as legal advisors.

Hubbell to Acquire Systems Control

Retrieved on: 
월요일, 10월 30, 2023
Wachtell, Lipton, Rosen & Katz, Ageing, Hubbell Incorporated, NYSE, Acquisition, Electricity, Engineering, Morgan Stanley, Growth, EPS, LLP, Systems control, Hand, McDermott Will & Emery, Automation, Electric power

Shelton, CT, Oct. 30, 2023 (GLOBE NEWSWIRE) -- Hubbell Incorporated (NYSE: HUBB) today announced that it has entered into a definitive agreement to acquire Northern Star Holdings, Inc. (commercially known as Systems Control), a portfolio company of Comvest Partners, for $1.1 billion in cash, subject to customary adjustments.

Key Points: 
  • Systems Control is a leading manufacturer of substation control and relay panels, as well as turnkey substation control building solutions.
  • Systems Control estimates 2024 sales of approximately $400 million.
  • Systems Control has a proven value proposition, with leading manufacturing quality and engineering expertise driving labor savings for utility customers while enabling them to operate critical infrastructure reliably and efficiently.
  • Harris Williams LLC and Lincoln International LLC are serving as financial advisors to Systems Control, and McDermott Will & Emery LLP is serving as legal advisor.

Recochem Acquired by CapVest from H.I.G. Capital

Retrieved on: 
월요일, 11월 6, 2023
Other Manufacturing, Finance, Aftermarket, Automotive, Chemicals, Plastics, Professional Services, Automotive Manufacturing, Manufacturing, CapVest Limited, H.I.G. Capital, Jefferies Group, Willkie Farr & Gallagher, Kirkland & Ellis, Multimedia, Growth, LLP, Partnership, Pleasure, Investment, McDermott Will & Emery, Blake, Cassels & Graydon, Management

and CapVest Partners LLP (“CapVest”) are pleased to announce that H.I.G portfolio company, Recochem (the “Company”), has been acquired by funds managed by CapVest.

Key Points: 
  • and CapVest Partners LLP (“CapVest”) are pleased to announce that H.I.G portfolio company, Recochem (the “Company”), has been acquired by funds managed by CapVest.
  • H.I.G, a leading global alternative investment firm, acquired Recochem in August 2018 in partnership with the Company’s management team.
  • Timothy Colson, Partner at CapVest, said: “We see significant strategic opportunities for Recochem to capitalize on in the future and look forward to working with the Recochem management team to continue to realize the Company’s tremendous potential.
  • Capital and Recochem as legal counsel in connection with the transaction.

Comvest Partners Enters in Definitive Agreement to Sell Systems Control to Hubbell Incorporated

Retrieved on: 
월요일, 11월 6, 2023
Finance, Consulting, Banking, Professional Services, Other Professional Services, Wachtell, Lipton, Rosen & Katz, Hubbell Incorporated, NYSE, Electricity, Morgan Stanley, Growth, Partnership, Systems control, McDermott Will & Emery, Electric power

Comvest Partners (“Comvest”), a middle-market private investment firm, is pleased to announce the execution of a definitive agreement to sell Systems Control (the “Company”) to Hubbell Incorporated (NYSE: HUBB), a leading manufacturer of utility and electrical solutions.

Key Points: 
  • Comvest Partners (“Comvest”), a middle-market private investment firm, is pleased to announce the execution of a definitive agreement to sell Systems Control (the “Company”) to Hubbell Incorporated (NYSE: HUBB), a leading manufacturer of utility and electrical solutions.
  • Systems Control has been a portfolio company in Comvest’s private equity strategy since 2018.
  • Founded in 1962 and headquartered in Iron Mountain, Mich., Systems Control is a leading manufacturer of substation control and relay panels as well as turnkey substation control building solutions for the electric transmission and distribution industry.
  • “Comvest invested in Systems Control in partnership with management with a shared vision of scaling the Company as a best-in-class turnkey provider of end-to-end substation control solutions.

Sheridan Capital Partners Announces Formation of Ascend Plastic Surgery Partners

Retrieved on: 
금요일, 10월 27, 2023
Surgery, Finance, Business, Professional Services, Practice Management, Other Health, Health, General Health, Other Professional Services, Day, Physician, Spell Capital Partners, Partnership, Partner, Patient, McDermott Will & Emery, Dentistry, Hospital

Sheridan Capital Partners (“Sheridan”) announced today the formation of Ascend Plastic Surgery Partners (“Ascend” or the “Company”), a plastic surgery physician practice management company.

Key Points: 
  • Sheridan Capital Partners (“Sheridan”) announced today the formation of Ascend Plastic Surgery Partners (“Ascend” or the “Company”), a plastic surgery physician practice management company.
  • Today, Ascend represents the combination of five plastic surgery practices and two standalone MedSpas.
  • Sheridan partnered with Dr. Hedden, along with a team of accomplished physicians, to establish Ascend Plastic Surgery Partners.
  • The transaction was led by Jonathan Lewis, Nicholas Rowland, Christopher McCrory, Stephen Lestyan, and Munib Ansari at Sheridan Capital Partners.

Sensorion to Participate in the Jefferies London Healthcare Conference and McDermott Will & Emery’s Life Sciences Symposium

Retrieved on: 
수요일, 10월 25, 2023
Health, Genetics, Other Health, Clinical Trials, Pharmaceutical, Biotechnology, Conference, Nawal, McDermott Will & Emery, Pharmaceutical industry

Sensorion (FR0012596468 – ALSEN) (Paris:ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat, and prevent within the field of hearing loss disorders, is pleased to announce its participation, in-person, at the Jefferies London Healthcare Conference and at McDermott Will & Emery’s Life Sciences Symposium.

Key Points: 
  • Sensorion (FR0012596468 – ALSEN) (Paris:ALSEN) a pioneering clinical-stage biotechnology company which specializes in the development of novel therapies to restore, treat, and prevent within the field of hearing loss disorders, is pleased to announce its participation, in-person, at the Jefferies London Healthcare Conference and at McDermott Will & Emery’s Life Sciences Symposium.
  • CEO Nawal Ouzren will attend Jefferies London Healthcare Conference in London, UK, on November 14-16, 2023.
  • Nawal will also attend McDermott Will & Emery’s European Health and Life Sciences Symposium 2023, in Paris, France, on November 7, 2023.
  • On this occasion, she will take part in a panel entitled “Transaction Trends in Life Sciences: New challenges and new opportunities in 2024”.